Peer-Led Intervention for HIV Postpartum Care
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a peer-led program designed to help pregnant and postpartum women living with HIV manage their health more effectively. The program aims to enhance confidence, support, and skills necessary for maintaining HIV care and controlling the virus after childbirth. Participants will attend sessions focused on either adhering to HIV treatment (WISH Adherence) or developing parenting skills (WISH Parenting). Women in their second or third trimester of pregnancy, living with HIV, and able to communicate in English may qualify for the trial. As an unphased trial, this study offers a unique opportunity to contribute to research that could significantly improve support systems for women living with HIV.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this peer-led intervention is safe for postpartum women living with HIV?
Research has shown that women with HIV must remain engaged in their healthcare after childbirth. Studies have found that adhering to HIV medication often becomes more challenging during this period, potentially impacting health. The WISH Adherence program aims to assist by providing support and information to help women maintain their treatment regimen.
This program is safe, as it involves no medical procedures or medications. It includes educational sessions led by a peer facilitator, focusing on conversation and planning. These sessions are generally manageable and have not been associated with any negative effects, as they aim to enhance understanding and support rather than involve physical treatment.12345Why are researchers excited about this trial?
Researchers are excited about the Peer-Led Intervention for HIV Postpartum Care because it focuses on personalized support through structured and unstructured sessions led by peer facilitators. Unlike standard HIV care, which primarily relies on healthcare providers for ART adherence, this approach empowers women by fostering self-efficacy and engagement through peer bonding and individualized planning. The intervention also distinguishes itself by incorporating parenting education, addressing both medical adherence and family dynamics, which is not typical in current treatment protocols. This dual focus aims to improve overall HIV care retention and ART adherence postpartum, potentially leading to better health outcomes for both mothers and their children.
What evidence suggests that this trial's treatments could be effective for postpartum HIV care?
This trial will compare two peer-led interventions for postpartum women with HIV: the WISH Adherence program and the WISH Parenting program. Studies have shown that women with HIV often struggle to maintain their HIV treatment and medical care after childbirth. Research indicates that peer support can be beneficial. In one study, women who participated in a peer-led program were more likely to consistently take their HIV medications. Specifically, they were 1.81 times more likely to adhere to their treatment compared to those who did not participate. This suggests that support from others in similar situations can significantly aid in managing HIV after childbirth.16789
Are You a Good Fit for This Trial?
This trial is for women living with HIV who are in their 2nd or 3rd trimester of pregnancy. They must be able to give informed consent, read and speak English, have access to a cell phone, and be at least 16 years old. Women planning to move out of the country within a year after giving birth cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Prenatal Intervention
Participants attend 3 face-to-face prenatal sessions with a peer facilitator to address barriers to outcome expectancies and self-efficacy.
Postpartum Intervention
Participants attend 2 face-to-face postpartum sessions to develop skills for ART adherence and engagement in HIV care.
Follow-up
Participants are monitored for retention in care and viral suppression up to 1 year postpartum.
What Are the Treatments Tested in This Trial?
Interventions
- WISH Adherence
- WISH Parenting
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator